PGS
ActiveSummary
PGS has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.12M and a net result of €517k. Equity is growing by ~54.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
short-term debt: 0.1% and cash: 25.9% of total assets, and 0.1% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
99.9%
Return on assets
45.9%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-08-2026, 11 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
11 d late
2024
61 d late
2023
30 d late
2022
60 d late
2021
30 d late
2020
66 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€1.12M▲ 85.1%
2024 · €607k
Total assets
€1.13M▲ 64.7%
2024 · €683k
Net result
€517k▲ 7.7%
2024 · €480k
Working capital
€984k▲ 77.7%
2024 · €554k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€180k▲ 30.5%€479k▲ 166%€572k▲ 19.5%€637k▲ 11.3%€649k▲ 2.0%
Net result€139k▲ 29.8%€362k▲ 161%€433k▲ 19.6%€480k▲ 10.9%€517k▲ 7.7%
Equity€246k▲ 129%€608k▲ 147%€452k▼ 25.7%€607k▲ 34.4%€1.12M▲ 85.1%
Total assets€265k▲ 103%€629k▲ 138%€467k▼ 25.8%€683k▲ 46.4%€1.13M▲ 64.7%
Debt€18k▼ 19.6%€21k▲ 12.9%€15k▼ 28.2%€76k▲ 412%€1k▼ 98.5%
Working capital€214k▲ 228%€586k▲ 174%€386k▼ 34.0%€554k▲ 43.3%€984k▲ 77.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 2% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.13M
Fixed assets
€141k ▲ 153%
Current assets
€985k ▲ 56.9%
Equity and liabilities €1.13M
Equity
€1.12M ▲ 85.1%
Debt
€1k ▼ 98.5%
Debt's share of the balance-sheet total falls from 11.1% to 0.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€671k▲
2024 · €659k
Cash flow
€538k▲
2024 · €503k
Debt to equity
0.00▼
2024 · 0.12
ROE
46.0%▼
2024 · 79.0%
ROA
45.9%▼
2024 · 70.3%
Interest coverage
722.65▲
2024 · 266.03
Debt ≤ 1 year
€1k▼
2024 · €74k
Income taxes
€163k▲
2024 · €154k
A ratio outside any meaningful range has been withheld (balance sheet total €1.13M, equity €1.12M).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €7 | €14k | - | €1k | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €12k | €12k | €19k | €23k | €21k | ▼ 5.1% |
| Other operating charges640/8 | €614 | €571 | €1k | €2k | €1k | ▼ 10.2% |
| Gross operating margin9900 | €193k | €491k | €592k | €661k | €672k | ▲ 1.7% |
| Operating profit (loss)9901 | €180k | €479k | €572k | €637k | €649k | ▲ 2.0% |
| Financial income75/76B | - | €0 | €0 | €104 | €32k | ▲ 30,416% |
| Recurring financial income75 | - | €0 | €0 | €104 | €32k | ▲ 30,416% |
| Financial charges65/66B | €735 | €746 | €730 | €2k | €928 | ▼ 62.5% |
| Recurring financial charges65 | €735 | €746 | €730 | €2k | €928 | ▼ 62.5% |
| Profit (loss) for the period before taxes9903 | €180k | €478k | €571k | €634k | €680k | ▲ 7.2% |
| Income taxes67/77 | €41k | €116k | €139k | €154k | €163k | ▲ 5.9% |
| Profit (loss) for the period9904 | €139k | €362k | €433k | €480k | €517k | ▲ 7.7% |
| Transfer to tax-exempt reserves689 | - | - | €126k | €147k | - | - |
| Profit (loss) for the period to be appropriated9905 | €139k | €362k | €306k | €333k | €517k | ▲ 55.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €265k | €629k | €467k | €683k | €1.13M | ▲ 64.7% |
| Fixed assets21/28 | €33k | €23k | €66k | €55k | €141k | ▲ 153% |
| Tangible fixed assets22/27 | €33k | €23k | €66k | €55k | €141k | ▲ 153% |
| Plant, machinery and equipment23 | €497 | €1k | €3k | €6k | €6k | ▼ 7.0% |
| Furniture and vehicles24 | €33k | €21k | €63k | €46k | €132k | ▲ 185% |
| Other tangible fixed assets26 | - | €516 | €402 | €3k | €3k | ▼ 10.4% |
| Current assets29/58 | €231k | €606k | €401k | €628k | €985k | ▲ 56.9% |
| Amounts receivable within one year40/41 | €8k | - | €19k | €28k | €517k | ▲ 1,750% |
| Trade receivables40 | - | - | €8k | €2k | - | - |
| Other amounts receivable41 | €8k | - | €11k | €26k | €517k | ▲ 1,912% |
| Current investments50/53 | - | - | - | €27k | €56k | ▲ 109% |
| Cash at bank and in hand54/58 | €212k | €530k | €258k | €423k | €292k | ▼ 31.0% |
| Deferred charges and accrued income490/1 | €12k | €75k | €123k | €150k | €120k | ▼ 19.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €265k | €629k | €467k | €683k | €1.13M | ▲ 64.7% |
| Equity10/15 | €246k | €608k | €452k | €607k | €1.12M | ▲ 85.1% |
| Contributions10/11 | €1k | €1k | €1k | €1k | €1k | = |
| Reserves13 | €245k | €607k | €451k | €606k | €606k | = |
| Tax-exempt reserves132 | - | - | €126k | €274k | €274k | = |
| Distributable reserves133 | €245k | €607k | €325k | €333k | €333k | = |
| Profit (loss) carried forward14 | - | - | - | - | €517k | - |
| Amounts payable17/49 | €18k | €21k | €15k | €76k | €1k | ▼ 98.5% |
| Amounts payable within one year42/48 | €18k | €20k | €14k | €74k | €1k | ▼ 98.5% |
| Trade debts44 | €213 | €54 | €147 | €3k | €616 | ▼ 79.5% |
| Suppliers440/4 | €213 | €54 | €147 | €3k | €616 | ▼ 79.5% |
| Taxes, remuneration and social security45 | €2k | €2k | €500 | €49k | €500 | ▼ 99.0% |
| Taxes450/3 | €2k | €2k | €500 | €49k | €500 | ▼ 99.0% |
| Other amounts payable47/48 | €15k | €18k | €13k | €22k | - | - |
| Accrued charges and deferred income492/3 | €666 | €698 | €682 | €2k | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €139k | €362k | €433k | €480k | €517k | ▲ 7.7% |
| + Depreciation and write-downs630 | €12k | €12k | €19k | €23k | €21k | ▼ 5.1% |
| Operating cash flow (approximation) | €151k | €374k | €452k | €503k | €538k | ▲ 7.1% |
| Investment in fixed assets (approximation) | - | €-2k | €-62k | €-12k | €-107k | ▼ 801% |
| Change in cash | - | €319k | €-272k | €165k | €-131k | ▼ 180% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 11 days late
2025
31-12
Financial
Highest result since 2020net €517k ▲7.7%
Operating result €649k, net result €517k, both a record.
31-12
Financial
Liquidity times 104current ratio 882.61
Current ratio from 8.45 to 882.61; short-term debt falls from €74k to €1k.
31-12
Financial
Equity above €1MEq €1.12M ▲85.1%
6 profitable years in a row build equity to €1.12M.
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Equity above €500kEq €607k ▲34.4%
5 profitable years in a row build equity to €607k.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
31-12
Financial
Liquidity doublescurrent ratio 30.35
Current ratio from 13.13 to 30.35.
31-12
Financial
Equity above €500kEq €608k ▲147%
3 profitable years in a row build equity to €608k.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
31-12
Financial
Liquidity triplescurrent ratio 13.13
Current ratio from 3.86 to 13.13; short-term debt falls from €23k to €18k.
31-12
Financial
Equity above €200kEq €246k ▲129%
2 profitable years in a row build equity to €246k.
05-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 66 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Deinze · 1 establishment unit since 2020
Ground area
2,903 m²
Building footprint
471 m²
Volume, LiDAR
1,468 m³
Parcel 44054B0927/00L002, Flanders · tallest building 5.1 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Ploegstraat 17, 9800 Deinze
since 20202.302.076.155
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44054B0927/00L002 | Flanders | 2,903 m² | 1 · 471 m² | 5.1 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SYNAPSIS
BE 0897.006.312
Ukkel · Eq €1,124,169
LND
BE 0887.871.484
Ukkel · Eq €1,124,963
NEGOR
BE 0447.038.653
Braine-l'Alleud · Eq €1,123,919
Chirurgie Maxillo - faciale - Caroline Gossiaux
BE 0501.570.271
Ukkel · Eq €1,125,856
DOKTER AMEYE FILIP - UROLOGIE
BE 0461.852.335
Nazareth-De Pinte · Eq €1,126,149
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 5,605 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded24-02-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.